Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse
Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse is organized by Physicians' Education Resource, LLC (PER).
Release Date: May 15, 2023
Expiration Date: May 15, 2024
Description:
Nurses play important roles in the management of patients with non–small cell lung cancer (NSCLC). Their roles include but are not limited to: considering therapeutic options, discussing these options with patients, and considering potential benefits versus adverse events of the therapeutic options. The use of molecular testing and biomarker-driven therapy has undergone marked growth and development for the management of NSCLC in recent years. As such, there is a critical need to provide education regarding the function of these tests, the emerging biomarkers, investigational therapies targeting current and emerging biomarkers, and their appropriate use to ultimately improve patients’ outcomes.
Learning Objectives:
• Explain recent molecular marker evidence in the context of counseling patients with NSCLC on the rationale for certain diagnostic tests
• Apply care plans for patients with cancer based on precision diagnostic approaches in NSCLC settings
• Describe efficacy and safety evidence from clinical trials that inform counseling by nurses of patients with NSCLC who are under their care.